Search research articles
Contact Us
Filters
Showing results (241-250 of 495) with videos related to
Page
of 50
Sort By:
Versicherungsmedizin
|
July 4, 2008
[Risk factor calculator for medical underwriting of life insurers based on the PROCAM study]
A Geritse, G Müller, T Trompetter, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 14, 1999
Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease
G Assmann, P Cullen, F Jossa, et al.
European Journal of Biochemistry
|
July 1, 1981
Displacement of the human apoprotein A-I by the human apoprotein A-II from complexes of (apoprotein A-I)-phosphatidylcholine-cholesterol
M Rosseneu, P Van Tornout, M J Lievens, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1983
Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins
G Schmitz, G Assmann, S C Rall, et al.
The Journal of Biological Chemistry
|
January 23, 1999
Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARalpha) in sterol carrier protein 2-/ sterol carrier protein x-deficient mice
P Ellinghaus, C Wolfrum, G Assmann, et al.
Revista Espanola De Cardiologia
|
January 1, 1987
[Strategy for the prevention of ischemic heart disease. Directives from the European Society of Atherosclerosis]
G Assmann, B Lewis, M Mancini, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 6, 2001
Phase II trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer
F Eckel, C Lersch, F Lippl, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 20, 2000
Use of longer extension phases to improve yield of high molecular weight products in differential display PCR
S Lorkowski, P Ellinghaus, E A Galinski, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 1, 1995
HDL3 stimulates multiple signaling pathways in human skin fibroblasts
M Walter, H Reinecke, J R Nofer, et al.
Clinical & Experimental Metastasis
|
September 1, 1996
Detection of the metastatic potential of blood-borne and immunomagnetically enriched epithelial cells by quantitative erbB-2 RT-PCR
B Brandt, C Griwatz, S Heidl, et al.
Page
of 50
Search research articles
Search
Showing results (241-250 of 495) with videos related to
Sort By:
Page
of 50
Versicherungsmedizin
|
July 4, 2008
[Risk factor calculator for medical underwriting of life insurers based on the PROCAM study]
A Geritse, G Müller, T Trompetter, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 14, 1999
Coronary heart disease: reducing the risk: the scientific background to primary and secondary prevention of coronary heart disease. A worldwide view. International Task force for the Prevention of Coronary Heart disease
G Assmann, P Cullen, F Jossa, et al.
European Journal of Biochemistry
|
July 1, 1981
Displacement of the human apoprotein A-I by the human apoprotein A-II from complexes of (apoprotein A-I)-phosphatidylcholine-cholesterol
M Rosseneu, P Van Tornout, M J Lievens, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1983
Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins
G Schmitz, G Assmann, S C Rall, et al.
The Journal of Biological Chemistry
|
January 23, 1999
Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARalpha) in sterol carrier protein 2-/ sterol carrier protein x-deficient mice
P Ellinghaus, C Wolfrum, G Assmann, et al.
Revista Espanola De Cardiologia
|
January 1, 1987
[Strategy for the prevention of ischemic heart disease. Directives from the European Society of Atherosclerosis]
G Assmann, B Lewis, M Mancini, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 6, 2001
Phase II trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer
F Eckel, C Lersch, F Lippl, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 20, 2000
Use of longer extension phases to improve yield of high molecular weight products in differential display PCR
S Lorkowski, P Ellinghaus, E A Galinski, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
November 1, 1995
HDL3 stimulates multiple signaling pathways in human skin fibroblasts
M Walter, H Reinecke, J R Nofer, et al.
Clinical & Experimental Metastasis
|
September 1, 1996
Detection of the metastatic potential of blood-borne and immunomagnetically enriched epithelial cells by quantitative erbB-2 RT-PCR
B Brandt, C Griwatz, S Heidl, et al.
Page
of 50